115 related articles for article (PubMed ID: 23177511)
1. High prevalence of normal serum albumin in NASH patients with ascites: a retrospective analysis.
Sourianarayanane A; O'Shea RS; Barnes DS; McCullough AJ
Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):246-53. PubMed ID: 23177511
[TBL] [Abstract][Full Text] [Related]
2. [Measurement of hepatic venous pressure gradient in liver cirrhosis: relationship with the status of cirrhosis, varices, and ascites in Korea].
Kim MY; Baik SK; Suk KT; Yea CJ; Lee IY; Kim JW; Cha SH; Kim YJ; Um SH; Han KH
Korean J Hepatol; 2008 Jun; 14(2):150-8. PubMed ID: 18617762
[TBL] [Abstract][Full Text] [Related]
3. Correlation of HVPG level with ctp score, MELD Score, ascites, size of varices, and etiology in cirrhotic patients.
Ramanathan S; Khandelwal N; Kalra N; Bhatia A; Dhiman RK; Duseja AK; Chawla YK
Saudi J Gastroenterol; 2016; 22(2):109-15. PubMed ID: 26997216
[TBL] [Abstract][Full Text] [Related]
4. Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis.
Kim TY; Lee JG; Sohn JH; Kim JY; Kim SM; Kim J; Jeong WK
Yonsei Med J; 2016 Jan; 57(1):138-45. PubMed ID: 26632394
[TBL] [Abstract][Full Text] [Related]
5. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
[TBL] [Abstract][Full Text] [Related]
6. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
[TBL] [Abstract][Full Text] [Related]
7. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
[TBL] [Abstract][Full Text] [Related]
8. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era.
Ripoll C; Bañares R; Rincón D; Catalina MV; Lo Iacono O; Salcedo M; Clemente G; Núñez O; Matilla A; Molinero LM
Hepatology; 2005 Oct; 42(4):793-801. PubMed ID: 16175621
[TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
[TBL] [Abstract][Full Text] [Related]
10. Correlation of hepatic venous pressure gradient with variceal bleeding, size of esophageal varices, etiology, ascites and degree of liver dysfunction in cirrhosis of liver.
Gulzar GM; Zargar SA; Jalal S; Alaie MS; Javid G; Suri PK; Shah NA; Bilal-Ul-Rehman ; Hakeem MS; Shoukat A; Dar GA
Indian J Gastroenterol; 2009; 28(2):59-61. PubMed ID: 19696990
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
[TBL] [Abstract][Full Text] [Related]
12. Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
Semmler G; Simbrunner B; Scheiner B; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Bauer D; Pinter M; Ferenci P; Trauner M; Mandorfer M; Reiberger T
J Gastroenterol Hepatol; 2019 Dec; 34(12):2164-2172. PubMed ID: 31062417
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
Rincon D; Lo Iacono O; Ripoll C; Gomez-Camarero J; Salcedo M; Catalina MV; Hernando A; Clemente G; Matilla A; Nuñez O; Bañares R
Aliment Pharmacol Ther; 2007 Apr; 25(7):841-8. PubMed ID: 17373923
[TBL] [Abstract][Full Text] [Related]
14. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
15. Stage of fibrosis and portal pressure correlation in nonalcoholic steatohepatitis.
Sourianarayanane A; Talluri J; Humar A; McCullough AJ
Eur J Gastroenterol Hepatol; 2017 May; 29(5):516-523. PubMed ID: 28079667
[TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension.
Garcia-Tsao G; Bosch J; Kayali Z; Harrison SA; Abdelmalek MF; Lawitz E; Satapathy SK; Ghabril M; Shiffman ML; Younes ZH; Thuluvath PJ; Berzigotti A; Albillos A; Robinson JM; Hagerty DT; Chan JL; Sanyal AJ;
J Hepatol; 2020 May; 72(5):885-895. PubMed ID: 31870950
[TBL] [Abstract][Full Text] [Related]
17. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient?
Park SH; Park HY; Kang JW; Park JS; Shin KJ; Kim CH; Suk KT; Baik GH; Kim JB; Kim DJ; Lee HY
Hepatogastroenterology; 2012; 59(120):2548-51. PubMed ID: 23178621
[TBL] [Abstract][Full Text] [Related]
18. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
[TBL] [Abstract][Full Text] [Related]
19. Cardiopulmonary hemodynamics and C-reactive protein as prognostic indicators in compensated and decompensated cirrhosis.
Turco L; Garcia-Tsao G; Magnani I; Bianchini M; Costetti M; Caporali C; Colopi S; Simonini E; De Maria N; Banchelli F; Rossi R; Villa E; Schepis F
J Hepatol; 2018 May; 68(5):949-958. PubMed ID: 29331339
[TBL] [Abstract][Full Text] [Related]
20. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]